Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#130)
mi
from
Phoenix, AZ
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#130)
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#130)
mi
from
Phoenix, AZ
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#130)
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#145)
mi
from
Prescott, AZ
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#145)
mi
from
Prescott, AZ
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#142)
mi
from
Tucson, AZ
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#142)
mi
from
Tucson, AZ
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#160)
mi
from
Los Angeles, CA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#160)
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Riverside, CA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Riverside, CA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#159)
mi
from
Roseville, CA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#159)
mi
from
Roseville, CA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#153)
mi
from
Arvada, CO
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#153)
mi
from
Arvada, CO
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#118)
mi
from
Aurora, CO
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#118)
mi
from
Aurora, CO
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Westminster, CO
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Westminster, CO
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#158)
mi
from
Waterbury, CT
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#158)
mi
from
Waterbury, CT
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#156)
mi
from
Columbus, GA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#156)
mi
from
Columbus, GA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Chicago, IL
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Michigan City, IN
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Michigan City, IN
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#115)
mi
from
New Orleans, LA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#115)
mi
from
New Orleans, LA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#147)
mi
from
Greenbelt, MD
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#147)
mi
from
Greenbelt, MD
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#117)
mi
from
Boston, MA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#117)
mi
from
Boston, MA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Springfield, MA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Springfield, MA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Detroit, MI
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Detroit, MI
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#134)
mi
from
Pontiac, MI
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#134)
mi
from
Pontiac, MI
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#152)
mi
from
Kansas City, MO
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#152)
mi
from
Kansas City, MO
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#152)
mi
from
Kansas City, MO
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#152)
mi
from
Kansas City, MO
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#141)
mi
from
Las Vegas, NV
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#141)
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#128)
mi
from
Buffalo, NY
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#128)
mi
from
Buffalo, NY
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#136)
mi
from
Northport, NY
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#136)
mi
from
Northport, NY
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#154)
mi
from
West Nyack, NY
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#154)
mi
from
West Nyack, NY
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Asheville, NC
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Asheville, NC
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Charlotte, NC
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#125)
mi
from
Durham, NC
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#125)
mi
from
Durham, NC
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#155)
mi
from
New Bern, NC
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#155)
mi
from
New Bern, NC
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#127)
mi
from
Winston-Salem, NC
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#127)
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#124)
mi
from
Cincinnati, OH
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#124)
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#123)
mi
from
Cleveland, OH
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#123)
mi
from
Cleveland, OH
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#123)
mi
from
Cleveland, OH
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#123)
mi
from
Cleveland, OH
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Columbus, OH
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#148)
mi
from
Parma Heights, OH
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#148)
mi
from
Parma Heights, OH
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#101)
mi
from
Philadelphia, PA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#101)
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#149)
mi
from
Pittsburgh, PA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#149)
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#146)
mi
from
Providence, RI
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#146)
mi
from
Providence, RI
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Chattanooga, TN
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Nashville, TN
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#119)
mi
from
Dallas, TX
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#119)
mi
from
Dallas, TX
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Houston, TX
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Houston, TX
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Midland, TX
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Midland, TX
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#132)
mi
from
Salt Lake City, UT
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#132)
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#107)
mi
from
Burlington, VT
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#107)
mi
from
Burlington, VT
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#129)
mi
from
Charlottesville, VA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#129)
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Fairfax, VA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Fairfax, VA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Fairfax, VA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Fairfax, VA
Click here to add this to my saved trials